Company Filing History:
Years Active: 2018-2019
Title: Stephen Denison Hauschka: Innovator in Cardiac and Muscular Dystrophy Research
Introduction
Stephen Denison Hauschka is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the fields of cardiac function and muscular dystrophy through his innovative research and patented technologies. With a total of 2 patents, Hauschka's work is paving the way for new treatments and therapies.
Latest Patents
Hauschka's latest patents include groundbreaking advancements in the treatment of muscular dystrophy and cardiac function. One of his patents focuses on micro-dystrophins and related methods of use. This patent provides nucleotide sequences that include a micro-dystrophin gene, which may be operatively linked to a regulatory cassette. The methods outlined in this patent aim to treat subjects who have, or are at risk of developing, muscular dystrophy, sarcopenia, heart disease, or cachexia. The pharmaceutical composition includes the micro-dystrophin gene and a delivery vehicle for administration to subjects, particularly those with Duchenne or Becker muscular dystrophy.
Another significant patent by Hauschka involves cell and gene-based methods to improve cardiac function. This patent details compositions and methods for enhancing myocardial contractility and relaxation in mammals. It describes the transfection of cardiomyocytes with expression vectors that encode ribonucleotide reductase subunits, which are then grafted to mammalian myocardium. The methods also include the delivery of dATP to the myocardium through grafting of donor cells that overexpress these subunits.
Career Highlights
Hauschka is affiliated with the University of Washington, where he continues to advance his research in the medical field. His work has garnered attention for its potential to revolutionize treatments for serious health conditions.
Collaborations
Hauschka has collaborated with notable researchers, including Jeffrey S Chamberlain and Julian Ramos. These partnerships have further enhanced the impact of his work in the scientific community.
Conclusion
Stephen Denison Hauschka is a key figure in the innovation of treatments for muscular dystrophy and cardiac function. His patents reflect a commitment to improving health outcomes through scientific research and collaboration. His contributions are vital to the ongoing advancements in medical therapies.